Non Pulmonary Effects of Isocyanates




© Springer Science+Business Media Singapore 2017
Takemi Otsuki, Claudia Petrarca and Mario Di Gioacchino (eds.)Allergy and Immunotoxicology in Occupational HealthCurrent Topics in Environmental Health and Preventive Medicine10.1007/978-981-10-0351-6_10


10. Non Pulmonary Effects of Isocyanates



Paola Pedata , Anna Rita Corvino1, Monica Lamberti1, Claudia Petrarca2, Luca Di Giampaolo3, Nicola Sannolo1 and Mario Di Gioacchino2, 4


(1)
Department of Experimental Medicine, Section of Hygiene, Occupational Medicine and Forensic Medicine, Second University of Naples, Naples, Italy

(2)
Immuntotoxicology and Allergy Unit & Occupational Biorepository, Center of Excellence on Aging and Translational Medicine (CeSI-MeT), “G. D’Annunzio” University Foundation, Chieti, Italy

(3)
Department of Medical Oral and Biotechnological Science, G. d’Annunzio University, Chieti, Italy

(4)
Department of Medicine and Science of Aging, G. d’Annunzio University, Chieti, Italy

 



 

Paola Pedata



Abstract

Isocyanates are highly reactive compounds of low molecular weight containing the functional group –N=C=O. Isocyanates are increasingly used in the fabrication of many products such as elastomers, paints, adhesive, coating, insecticides, and resins with a variety of industrial applications after polymerization with alcohols to form polyurethanes. The high chemical reactivity of isocyanates, an important characteristic in industrial applications, also makes them toxic products. Isocyanates currently are the most commonly identified cause of occupational asthma in industrialized countries. Exposure to diisocyanates, polyisocyanates, and polyurethane additives may also cause allergic and irritant contact dermatitis (ACD, ICD) and may result in neurotoxic and carcinogenic effects.

The purpose of this paper is to review and synthesize the literature regarding non-pulmonary health effects of isocyanates to address several key unresolved issues, including the carcinogenic and neurotoxic effects, and to focus on the often unrecognized skin effects.


Keywords
IsocyanatesHealth effectsCarcinogenic effectsNeurotoxic effectsSkin effects



10.1 Introduction


Isocyanates are highly reactive compounds of low molecular weight containing the functional group –N=C=O.

Isocyanates are classified, based on number of N=C=O groups in the molecules, into monoisocyanates (one NCO), diisocyanates (two NCO), or polyisocyanates (multiple NCOs). In diisocyanate, the two functional groups can directly polymerize with alcohols to form polyurethanes, resins with a variety of industrial applications. Polyisocyanates represent the major source of exposure to isocyanate groups in many workplaces, and like the diisocyanate monomers from which they are derived, such as toluene diisocyanate (TDI), diphenylmethane diisocyanate (MDI), and hexamethylene diisocyanate (HDI), they are increasingly used in the production of elastomers, paints, adhesives, coatings, insecticides, and many other products.

Aliphatic isocyanates such as those based on HDI are used mostly in external paints and coatings because of their excellent resistance to chemicals and abrasion and superior weathering characteristics such as gloss and color retention.

Aromatic isocyanates, such as MDI, are used in many applications such as foams, adhesives, sealants, elastomers and binders, which require fast curing rates and have less stringent requirements on their chemical and mechanical stability.

Polyurethane foams are a major end use of aromatic isocyanates [1]. There are several reports of sensitization to polyurethane products also in a domestic setting, such as to a plastic watchstrap, spectacle frames, and a pacemaker lining due to the increasing popularity of “do it yourself”; for this reason, isocyanates are likely to become more common chemicals within houses [2].

The high chemical reactivity of isocyanates, an important characteristic in their industrial use, also makes them toxic. Despite substantial research on isocyanates, the pathogenic mechanisms, host susceptibility factors, and dose-response relationships remain unclear [35]. Isocyanates can bind to carrier proteins, via the reaction of the NCO group with nucleophiles such as SH, NH2, NH, and OH groups present on these proteins. Several peptides and proteins found in airway epithelial cells, serum, and skin have been observed to bind diisocyanates, including glutathione [6, 7], albumin [8, 9], tubulin [10], and keratin [9, 11]. Covalent binding of isocyanate groups to carrier proteins is likely an important step in the chain of events leading to health effects, in particular sensitization and asthma [1].

Respiratory exposure to isocyanates has long been considered the primary way of exposure, and thus, research, regulation, and prevention have focused almost exclusively on airborne isocyanate exposures [12]. However, respiratory exposures have been reduced through improved hygiene controls and the use of less-volatile isocyanates [1], thus potentially increasing the relative importance of skin exposure. Numerous isocyanate end uses, such as spraying and application of foams and adhesives, may cause isocyanate skin exposure from deposition of aerosols and/or absorption of vapors. Typical workplace isocyanate exposure levels are not irritating and give few warning signs and skin protective equipment may not be worn, even when respiratory protection is used [13]. Skin exposure is the consequence of direct contact of unprotected skin or the failure of personal protective equipments, like gloves; particularly events such as spills, cleanup, and contact with contaminated equipments represent the major opportunities for isocyanate skin exposure. There are some investigations showing that isocyanates [14] and solvents [15] can be detected underneath gloves.

Isocyanate skin exposure could contribute a significant part of the total body burden. Multiple lines of evidence from animal studies and clinical, epidemiologic, and biomarker studies, as well as anecdotal evidence, suggest that in certain exposure setting, human skin likely is an important route of isocyanate exposure and can contribute to the development of isocyanate health effects [16].

Isocyanates currently are the most commonly identified cause of occupational asthma in industrialized countries, where its prevalence among exposed workers ranges from 1 % to even 25 %. These chemicals were also reported as causal factors of other respiratory disorders as nonobstructive bronchitis, rhinitis, chronic obstructive pulmonary disease, and less commonly extrinsic allergic alveolitis [16, 17].

Several observations suggest that skin exposure occurs and can contribute to the development of isocyanate asthma presumably by inducing systemic sensitization. In fact, isocyanate respiratory exposure alone, without any skin exposure, seems unlikely in most work settings. Isocyanate asthma occurs in settings with minimal documented respiratory exposures but clear potential for skin exposure, and splashes and spills have been reported by workers who subsequently develop isocyanate asthma [1822].

Exposure to diisocyanates, polyisocyanates, and polyurethane additives may also cause allergic and irritant contact dermatitis [23]. Contact hypersensitivity (allergic contact dermatitis) following skin exposure to isocyanates is well documented in animals and in clinical dermatologic literature, with sensitization confirmed with patch testing [24, 25]. Allergic contact dermatitis has been reported following skin exposure to isocyanates and polyurethane products in a number of different workplace and non-occupational settings, but has not been considered common and is rarely reported in workers with isocyanate asthma [24, 2628]. However, allergic contact dermatitis may be more common than suspected because symptoms can be mild, workers being evaluated for asthma are frequently not asked about skin problems, and patch testing can be falsely negative [24, 29].

Another potential health disease related to exposure to isocyanates are neurotoxic effects consisting in lightheadedness, headache, insomnia, mental aberrations, impaired gait, loss of consciousness, and coma due to acute exposure and alterations in the central and peripheral nervous systems for chronic exposure. Moreover, a systematic review of the literature evaluating the causal association on humans does not exist to support this alleged association [30].

Another open question is whether occupational isocyanate exposure is a carcinogenic hazard. TDI has been classified as carcinogenic in animals on the basis of gavage administration studies, but no conclusions are available on inhalation exposure. TDI is classified as a Group 2B carcinogen (possibly carcinogenic to humans) by the International Agency for Research on Cancer (IARC) [31] and as an A4 carcinogen (not classifiable as a human carcinogen) by the American Conference of Governmental Industrial Hygienists (ACGIH) [32]. For MDI, there is suggestive evidence for carcinogenicity in rats. Both chemicals have been positive in a number of short-term tests inducing gene mutations and chromosomal damage [33].

Over the past several years, there has been an increasing collection of clinical and epidemiologic data related to isocyanate health effects, especially those regarding respiratory ones, although knowledge and awareness remain limited regarding the non-pulmonary effects of isocyanates and some clinical studies are still unrecognized. Our purpose in this paper is to review and synthesize the literature regarding non-pulmonary effects of isocyanates to address several key unresolved issues, including the carcinogenic and neurotoxic effects of isocyanates, and to focus on the often unrecognized skin effects.


10.2 Literature Search


We selected the most relevant contributions to the literature in clinical and epidemiologic fields starting with the information retrieved from PubMed (http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​), Google Scholar (http://​scholar.​google.​com), and ScienceDirect (www.​sciencedirect.​com) using the following keywords: “isocyanates” OR “diisocyanates” OR “MDI” OR “TDI” OR “HDI”, AND “health effects”, AND “skin disease” OR “sensitization”, AND “cancerogenesis” AND “neurotoxicity”, and other synonymous terms and our own extensive collection of isocyanate publications. Additional papers were identified from the reference lists of the selected relevant articles.

The search yielded about 110 articles which were further reviewed; at the end of this selection process, 82 articles were deemed relevant to this review and were examined with a particular emphasis on non-pulmonary effects of isocyanates, such as skin diseases and neurotoxic and carcinogenic effects.


10.3 Health Effects



10.3.1 Skin Diseases


The isocyanates are an important cause of occupational asthma, but descriptions of ACD and ICD due to them are relatively uncommon [24]. In a mouse local lymph node assay examining the dermal sensitization potential of TDI, Woolhiser et al. [34] reported irritation at the TDI application site [34]. Second, Arnold et al. [35] reported that the animal studies are insufficient to characterize the dermal irritation potential of TDI due to the lack of documentation and use of nonstandard methodology; the overall weight of evidence indicates that TDI is irritating to the skin of experimental animals [35].

ACD caused by isocyanates has been reported mainly in connection with occupational exposure in the manufacture of polyurethane products used in the plastics, car and textile industries, flooring, and the manufacture of medical, electronic, and foam products. It has also been reported in sculptors [36] and a molders [37], although there is still limited knowledge about the skin diseases in occupational setting because the fact that most studies to date have been cross-sectional in design, small in size, or based on selected clinical cases or production workers rather than end use workers.

One of the first investigations on the skin effects of polyurethane products is that of Emmet et al.; this study reported skin rashes on exposed skin areas in eight workers of polyurethane molding plant, with positive patch test reactions to dicyclohexylmethane-4,4′-diisocyanate (DMDI, synonymous with hydrogenated methylene-4,4′-diphenyl diisocyanate – HDI) and diaminodiphenylmethane (MDA) in two of them [38]. White et al. showed ACD and ICD due to DMDI in uncured resin in a factory of car badges [39]. Frick et al. demonstrated ACD in workers of a company manufacturing flooring laminate boards, after the introduction of a water-repellent lacquer based on MDI. Five workers, engaged as machine operators where lacquer was sprayed onto the boards, developed eczematous lesions of the forearms, hands, or arms. Patch testing showed positive reactions to MDA in four, to MDI in one, to HDMI in one, and to a lacquer in three of them [40]. Another study of Frick et al. reported severe eczema in 17 workers exposed to glue based on DMDI, at a factory manufacturing medical equipment. Contact allergy to DMDI, other isocyanates, and/or MDA was demonstrated in 13 individuals [27].

Isolated cases of ACD in workers exposed to MDI were also reported in different occupational environment. Hannu et al. demonstrated a case of ACD due to MDI and MDA from accidental occupational exposure in a female worker of a manufacturing plant of electronic components [41]. Schroder reported a case of ACD to MDI, present in polyurethane adhesive, TDI, MDA, and epoxy resin in a female engaged in a plant manufacturing grinding tools [42]. Estlander et al. diagnosed occupational contact dermatitis in three workers exposed to MDI present, respectively, in a hardener of core binder, a hardener of adhesive, and a laboratory mixture of diisocyanates [43]. Lidén reported a case of ACD of the forearms in a molder exposed to MDI-containing product in a hospital [37]. Tait and Delaney reported a case of a maintenance fitter who developed ACD after cleaning filters contaminated with aptane isocyanate based on MDI [44]. Kerre reports a patient who developed an acute allergic contact dermatitis using a DMDI-charged cartridge to create resin-coated “3D labels” within an office environment [45].

According to Aalto-Korte et al. who analyzed 54 cases of ACD due to monomeric isocyanates, motor vehicle industry was among the most significant occupational fields for isocyanate contact allergy. They identified many sources of allergy to MDI such as polyurethane foam used in the production of car insulation material, pistol foam containing MDI, and uncured polyurethane insulation material [46]. A recent study of Kiec-Swierczynska et al. in a vehicle equipment factory revealed work-related contact dermatitis in 12 workers exposed to polyurethane foam containing MDI. Seven of them developed contact allergy to MDA and were diagnosed with occupational ACD. Irritant skin reactions to the antiadhesive agent were also observed, in three cases coexisting with occupational ACD [47].

There are several reports of sensitization to polyurethane products also in domestic setting, such as to a plastic watchstraps [26], spectacle frames [48], a pacemaker lining [49], and do-it-yourself products used for renovating objects [2], though only one of these reports has been specifically identified, sensitization to 1,6-hexamethylene diisocyanate. It is also described a case of allergic contact dermatitis caused by isocyanates, specifically DMDI, in resin jewelry making. Furthermore, this is not occupational related [50].

Isocyanates causing allergy contact dermatitis included MDI [24, 37, 4143], TDI [24], HDI [24, 51], and DMDI [27, 39, 45, 52, 53]. Allergy contact dermatitis due to MDI was seen more frequently than that related to other isocyanates, which may be a consequence of the fact that MDI represents more than a half of the worldwide isocyanate production [46].

Occupational allergic contact dermatitis usually develops after months or years of exposure. However, strong allergens may sensitize after a single exposure [54]. According to Kanerva et al., one can assume that sensitization from a single exposure has taken place when a patient, with no previous eczema, develops the first skin symptoms soon after accidental exposure and patch testing with the chemical provokes an allergic reaction.

The most common locations of occupational dermatitis are generally the hands and forearms, but the face is also commonly affected. In a report from a general dermatology clinic, facial symptoms were more common among TDI-positive or isophorone diisocyanate (IPDI)-positive cases than among MDA-positive or MDI-positive ones [55]. Although in later investigations no difference was noted when MDI-positive patients were compared with IPDI-positive or TDI-positive cases, facial symptoms resulted not so common in patients reacting only to MDA [46].

Moreover, cases of urticaria due to MDI were demonstrated [5658]. Particularly, Stingeni et al. reported a case of nonatopic man with breathing difficulties for 3 months and urticaria on his face (mala and mandibular areas) for 2 months who worked in a chemical factory manufacturing adhesives and 1 year previously had been assigned to the mixing of polyurethane glues. The symptoms developed a few minutes after every working exposure to the Isonate M143 glue containing diphenylmethane-4,4′-diisocyanate (MDI). This study is the first report of concomitant type I and type IV sensitivities to MDI, as respectively shown by the immediate urticaria-type patch test reaction to Isonate M143, positive radioallergosorbent test to MDI, and delayed positive patch test to MDI and Isonate M143 serial dilutions. Contact urticaria belongs to the class of immediate skin immune response, as also proved by specific IgE antibodies against MDI detected in the patient.


10.3.2 Neurotoxicity


Limited number of studies suggests potential neurotoxic effects from exposures to isocyanates; acute exposure to high levels of TDI vapor has been associated with lightheadedness, headache, insomnia, mental aberrations, impaired gait, loss of consciousness, and coma, while chronic exposures have been associated with alterations in the central and peripheral nervous systems.

One of the first case reports, conducted in 1987, described the accidental exposure of three wharf workers at TDI during an accidental chemical spill. Compared with 2 months postexposure, at 16 months postexposure, Full Scale Intelligence Quotient (IQ) dropped an average of 23 points. Results from additional neuropsychological testing at 16 months postexposure indicated severe deficits in all three subjects in memory, manual dexterity, visuomotor tracking, mental flexibility, ability to detect figure-ground relationships, and word fluency [59].

Reyde et al. reported results of neuropsychological functioning of five men suffering alleged physical, cognitive, and behavioral changes following exposure to MDI. All workers reported experiencing subjective symptoms consisting of respiratory distress, headaches, depression, irritability, decreased calculating ability, and reduced concentration. Wechsler Adult Intelligence Scale-Revised IQ revealed in four of the five subjects weakness on the digit symbol subtest and in attention-concentration testing. The authors concluded that neuropsychological test data support the presence of behavioral and cognitive correlates of CNS injury following exposure to MDI [60].

Recently, Moshe et al. described a case report of a 60-year-old Israeli painter/artist with central and peripheral neuropathic findings. His work was unusual in that he painted large posters with different mixtures of organic solvents, including toluene, xylene, benzene, methyl ethyl ketone, TDI, acetone, and thinner. He did not use any protective gloves and did not wear a mask. After 30 years as a painter, he developed weakness and paresthesia of the hands and feet, intention tremor, and difficulty concentrating with memory deficits. He had mild atrophy and distal weakness of both upper and lower limbs and demonstrated bradykinesia. He was evaluated with several methods and was diagnosed as having peripheral and central neuropathy, including ototoxic hearing loss because of long exposures to organic solvents [61].

In recent years, a systematic review conducted by Hughes et al. demonstrated a lack of quality epidemiological studies in the literature on neurotoxic health effects and exposure to diisocyanates. The available evidence consists mostly of case reports and case series, some of which are listed above. Using the Hill criteria or considerations for causality, the authors found limited evidence for strength of association and consistency [30].

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Oct 26, 2017 | Posted by in GENERAL SURGERY | Comments Off on Non Pulmonary Effects of Isocyanates

Full access? Get Clinical Tree

Get Clinical Tree app for offline access